MannKind expands United Therapeutics partnership for second inhaled therapy
Go back to MannKind expands United Therapeutics partnership for second inhaled therapy| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.52 +0.47 (11.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $2.51 | |||
| Open | $4.09 | 52 Week Low | $0.41 | |||
| Day High | $4.55 | P/E | N/A | |||
| Day Low | $4.08 | EPS | $-0.64 | |||
| Volume | 9,573,417 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 555.91 +8.76 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $547.15 | 52 Week High | $164.04 | |||
| Open | $554.94 | 52 Week Low | $97.52 | |||
| Day High | $558.59 | P/E | 101.63 | |||
| Day Low | $547.63 | EPS | $5.47 | |||
| Volume | 534,365 | |||||
